1. Home
  2. STTK vs MYFW Comparison

STTK vs MYFW Comparison

Compare STTK & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.14

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

MYFW

First Western Financial Inc.

HOLD

Current Price

$26.08

Market Cap

220.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
MYFW
Founded
2016
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
220.8M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
STTK
MYFW
Price
$3.14
$26.08
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
$4.00
$24.25
AVG Volume (30 Days)
328.1K
26.2K
Earning Date
11-06-2025
01-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
391.62
EPS
N/A
1.28
Revenue
$1,000,000.00
$95,514,000.00
Revenue This Year
N/A
$15.96
Revenue Next Year
N/A
$13.77
P/E Ratio
N/A
$20.10
Revenue Growth
N/A
19.92
52 Week Low
$0.69
$17.10
52 Week High
$3.38
$26.28

Technical Indicators

Market Signals
Indicator
STTK
MYFW
Relative Strength Index (RSI) 71.00 74.03
Support Level $1.93 $23.72
Resistance Level $3.30 $26.28
Average True Range (ATR) 0.23 0.56
MACD 0.09 0.21
Stochastic Oscillator 80.69 89.95

Price Performance

Historical Comparison
STTK
MYFW

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: